Ligand validation:4E0D

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4E0D_MES_A_909	40%	18%	0.141	0.851	1.9	1.62	1	2	0	0	100%	0.66
4DQQ_MES_A_905	48%	12%	0.153	0.897	2.06	2.03	2	5	2	0	100%	0.67
1NK0_MES_A_2	26%	45%	0.214	0.853	1.41	0.75	3	-	0	0	100%	1
2XY6_MES_A_1879	8%	7%	0.373	0.847	2.18	2.63	1	6	3	0	100%	0.4
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	23%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	21%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	62%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.